The autophagy qRT-PCR tool used on trastuzumab-refractory breast cancer cells allowedfor the rapid and accurate identification of differentially expressed autophagy genes (e.g.,ATG12) that were causally associated with intrinsic resistance to the anti-tumoral effectsof the molecularly targeted anti-HER2 drugs. Here, ATG12 is linked to breast cancer.